Targeted Next-Generation Sequencing in Molecular Subtyping of Lower-Grade Diffuse Gliomas: Application of the World Health Organization's 2016 Revised Criteria for Central Nervous System Tumors.
暂无分享,去创建一个
Jonathan W Heusel | Eric J Duncavage | Catherine E Cottrell | Samantha N McNulty | Samantha N. McNulty | Patrick J Cimino | E. Duncavage | P. Cimino | C. Cottrell | Katinka A. Vigh-Conrad | J. Heusel | Katinka A Vigh-Conrad | Jamal H Carter | K. Vigh-Conrad | Jamal H. Carter
[1] Jiang Li,et al. Finding the lost treasures in exome sequencing data. , 2013, Trends in genetics : TIG.
[2] D K Pearl,et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.
[3] Pieter Wesseling,et al. International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading , 2014, Brain pathology.
[4] B. Scheithauer,et al. Supratentorial gliomas: a comparative study by grade and histologic type , 1997, Journal of Neuro-Oncology.
[5] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[6] Ken Chen,et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples , 2009, Bioinform..
[7] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[8] Winand N M Dinjens,et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Shaw,et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] David Wang,et al. Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data. , 2014, Experimental and molecular pathology.
[11] C. Suter,et al. Oligoastrocytomas: throwing the baby out with the bathwater? , 2014, Acta Neuropathologica.
[12] J. Eshleman,et al. Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis. , 2011, The Journal of molecular diagnostics : JMD.
[13] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..
[14] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[15] A. Perry. Oligodendroglial Neoplasms: Current Concepts, Misconceptions, and Folklore , 2001, Advances in anatomic pathology.
[16] David T. W. Jones,et al. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma , 2014, Acta Neuropathologica.
[17] H. Bloom,et al. Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. , 1990, International journal of radiation oncology, biology, physics.
[18] Howard Colman,et al. IDH1 and IDH2 Mutations in Gliomas , 2013, Current Neurology and Neuroscience Reports.
[19] Alexander R. Pico,et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.
[20] B. Bastian,et al. CNVkit: Copy number detection and visualization for targeted sequencing using off-target reads , 2014, bioRxiv.
[21] Rakesh Nagarajan,et al. Clinical next‐generation sequencing in patients with non–small cell lung cancer , 2015, Cancer.
[22] Jos Jonkers,et al. CopywriteR: DNA copy number detection from off-target sequence data , 2015, Genome Biology.
[23] H. Abel,et al. A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel. , 2015, Experimental and molecular pathology.
[24] Savita Shrivastava,et al. Validation of a next-generation sequencing assay for clinical molecular oncology. , 2014, The Journal of molecular diagnostics : JMD.
[25] David T. W. Jones,et al. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma , 2014, Acta Neuropathologica.
[26] T. Yoshimine,et al. IDH1/2 mutation detection in gliomas , 2015, Brain Tumor Pathology.
[27] A. von Deimling,et al. Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes , 2010, The American journal of surgical pathology.
[28] L. Diaz,et al. Genetic Classification of Gliomas: Refining Histopathology. , 2015, Cancer cell.
[29] B. Fisher,et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[31] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[32] Steven J. M. Jones,et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.
[33] Somak Roy,et al. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. , 2016, Neuro-oncology.
[34] C. Daumas-Duport,et al. Postoperative radiotherapy of supratentorial low-grade gliomas. , 1989, International journal of radiation oncology, biology, physics.